CCL20, C-C motif chemokine ligand 20, 6364

N. diseases: 242; N. variants: 3
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Diabetes Mellitus, Insulin-Dependent
0.300 Therapeutic disease CTD_human CCL20 peptides, which block CCR6 binding to CCL20, inhibited development of type 1 diabetes. 21340626 2011
CUI: C0019207
Disease: Hepatoma, Morris
Hepatoma, Morris
0.300 Biomarker disease CTD_human Pancreatic carcinoma cells colonizing the liver modulate the expression of their extracellular matrix genes. 30603057 2018
CUI: C0019208
Disease: Hepatoma, Novikoff
Hepatoma, Novikoff
0.300 Biomarker disease CTD_human Pancreatic carcinoma cells colonizing the liver modulate the expression of their extracellular matrix genes. 30603057 2018
CUI: C0030297
Disease: Pancreatic Neoplasm
Pancreatic Neoplasm
0.300 Biomarker disease CTD_human Pancreatic carcinoma cells colonizing the liver modulate the expression of their extracellular matrix genes. 30603057 2018
CUI: C0032285
Disease: Pneumonia
Pneumonia
0.300 Biomarker disease CTD_human Expansion of CD4(+) CD25(+) and CD25(-) T-Bet, GATA-3, Foxp3 and RORγt cells in allergic inflammation, local lung distribution and chemokine gene expression. 21625544 2011
CUI: C0032300
Disease: Lobar Pneumonia
Lobar Pneumonia
0.300 Biomarker disease CTD_human Expansion of CD4(+) CD25(+) and CD25(-) T-Bet, GATA-3, Foxp3 and RORγt cells in allergic inflammation, local lung distribution and chemokine gene expression. 21625544 2011
CUI: C0038433
Disease: Streptozotocin Diabetes
Streptozotocin Diabetes
0.300 Therapeutic disease CTD_human Prevention and treatment of diabetes with resveratrol in a non-obese mouse model of type 1 diabetes. 21340626 2011
CUI: C0086404
Disease: Experimental Hepatoma
Experimental Hepatoma
0.300 Biomarker disease CTD_human Pancreatic carcinoma cells colonizing the liver modulate the expression of their extracellular matrix genes. 30603057 2018
CUI: C0205734
Disease: Diabetes, Autoimmune
Diabetes, Autoimmune
0.300 Therapeutic disease CTD_human Prevention and treatment of diabetes with resveratrol in a non-obese mouse model of type 1 diabetes. 21340626 2011
CUI: C0274861
Disease: Arsenic Poisoning, Inorganic
Arsenic Poisoning, Inorganic
0.300 Biomarker disease CTD_human Gene expression profiles in peripheral lymphocytes by arsenic exposure and skin lesion status in a Bangladeshi population. 16835338 2006
Nervous System, Organic Arsenic Poisoning
0.300 Biomarker disease CTD_human Gene expression profiles in peripheral lymphocytes by arsenic exposure and skin lesion status in a Bangladeshi population. 16835338 2006
CUI: C0311375
Disease: Arsenic Poisoning
Arsenic Poisoning
0.300 Biomarker disease CTD_human Gene expression profiles in peripheral lymphocytes by arsenic exposure and skin lesion status in a Bangladeshi population. 16835338 2006
CUI: C0342302
Disease: Brittle diabetes
Brittle diabetes
0.300 Therapeutic disease CTD_human Prevention and treatment of diabetes with resveratrol in a non-obese mouse model of type 1 diabetes. 21340626 2011
CUI: C0751851
Disease: Arsenic Encephalopathy
Arsenic Encephalopathy
0.300 Biomarker disease CTD_human Gene expression profiles in peripheral lymphocytes by arsenic exposure and skin lesion status in a Bangladeshi population. 16835338 2006
CUI: C0751852
Disease: Arsenic Induced Polyneuropathy
Arsenic Induced Polyneuropathy
0.300 Biomarker disease CTD_human Gene expression profiles in peripheral lymphocytes by arsenic exposure and skin lesion status in a Bangladeshi population. 16835338 2006
CUI: C0887898
Disease: Experimental Lung Inflammation
Experimental Lung Inflammation
0.300 Biomarker disease CTD_human Expansion of CD4(+) CD25(+) and CD25(-) T-Bet, GATA-3, Foxp3 and RORγt cells in allergic inflammation, local lung distribution and chemokine gene expression. 21625544 2011
CUI: C1257931
Disease: Mammary Neoplasms, Human
Mammary Neoplasms, Human
0.300 Biomarker disease CTD_human ERE-independent ERalpha target genes differentially expressed in human breast tumors. 16298037 2005
CUI: C3714636
Disease: Pneumonitis
Pneumonitis
0.300 Biomarker disease CTD_human Expansion of CD4(+) CD25(+) and CD25(-) T-Bet, GATA-3, Foxp3 and RORγt cells in allergic inflammation, local lung distribution and chemokine gene expression. 21625544 2011
CUI: C3837958
Disease: Diabetes Mellitus, Ketosis-Prone
Diabetes Mellitus, Ketosis-Prone
0.300 Therapeutic disease CTD_human Prevention and treatment of diabetes with resveratrol in a non-obese mouse model of type 1 diabetes. 21340626 2011
CUI: C4554117
Disease: Diabetes Mellitus, Sudden-Onset
Diabetes Mellitus, Sudden-Onset
0.300 Therapeutic disease CTD_human Prevention and treatment of diabetes with resveratrol in a non-obese mouse model of type 1 diabetes. 21340626 2011
CUI: C4704874
Disease: Mammary Carcinoma, Human
Mammary Carcinoma, Human
0.300 Biomarker disease CTD_human ERE-independent ERalpha target genes differentially expressed in human breast tumors. 16298037 2005
CUI: C0011881
Disease: Diabetic Nephropathy
Diabetic Nephropathy
0.220 Biomarker disease BEFREE Targeting pro-inflammatory chemokine MIP-3α and its signaling pathways will provide novel strategy to treat diabetic kidney disease. 21109018 2011
CUI: C0011881
Disease: Diabetic Nephropathy
Diabetic Nephropathy
0.220 Biomarker disease RGD In summary, we have uniquely demonstrated that high glucose increases MIP-3 alpha through a TGF beta 1 dependent pathway, suggesting the centrality of TGF-beta1 in both the inflammatory and previously demonstrated fibrotic responses in diabetic nephropathy. 17664181 2007
CUI: C0011881
Disease: Diabetic Nephropathy
Diabetic Nephropathy
0.220 Biomarker disease BEFREE In summary, we have uniquely demonstrated that high glucose increases MIP-3 alpha through a TGF beta 1 dependent pathway, suggesting the centrality of TGF-beta1 in both the inflammatory and previously demonstrated fibrotic responses in diabetic nephropathy. 17664181 2007
CUI: C0007786
Disease: Brain Ischemia
Brain Ischemia
0.200 Biomarker disease RGD A novel rat CC chemokine, identified by targeted differential display, is upregulated in brain inflammation. 9916893 1998